{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T11:05:58Z","timestamp":1764846358610,"version":"3.46.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes","award":["JYY2023-8"],"award-info":[{"award-number":["JYY2023-8"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC3044700"],"award-info":[{"award-number":["2024YFC3044700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Jishuitan Research Funding","award":["KYYC202301"],"award-info":[{"award-number":["KYYC202301"]}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["BJRITO-RDP-2024"],"award-info":[{"award-number":["BJRITO-RDP-2024"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoporosis and subsequent fractures not only seriously threaten the health of the aging but also escalate healthcare costs and social burdens. Undoubtedly, it is necessary to constantly optimize the diagnosis and treatment of osteoporotic fractures, and further understanding and investigation of the related studies is indispensable. However, the research on osteoporotic fractures is difficult to summarize, with complicated content and multiple disciplines involved. Consequently, this bibliometric analysis was conducted to gain a comprehensive understanding and grasp the hot topic of osteoporosis worldwide, which is beneficial to precisely guide research trends and demonstrate emerging treatments and preventive strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The literature published between January 2014 and October 2024 was systematically searched in the Web of Science Core Collection (WoSCC). Visualization software, including Vosviewer and CiteSpace, was used to conduct the analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 6682 publications were obtained from 2014 to 2024 for bibliometric analysis. The USA is far ahead of other countries in both the number of publications and frequency of citations, with extensive co-authorship collaborations with nearly all other countries. Cyrus Cooper is the most influential author, and the University of Sheffield is the most influential organization in the related fields. The keywords are categorized as 6 clusters, including \u201chip fracture,\u201d \u201cbone turnover,\u201d \u201cdenosumab,\u201d \u201catypical femoral fracture,\u201d \u201cvitamin D,\u201d and \u201cbone strength\u201d. The ongoing hotspots include \u201cteriparatide,\u201d \u201chip,\u201d \u201cfragility fractures,\u201d and \u201coutcome\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study comprehensively summarizes the topic trends and developments in the field of osteoporotic fractures using bibliometric analysis over the past decade. The hotspots and frontiers mainly focused on the prediction of osteoporosis and fractures, drug treatment, and clinical management. The intersection of multiple disciplines and various emerging frontiers has provided great potential for the management of osteoporotic fractures. Further investigation and more clinical translation are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-025-01620-6","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:26:58Z","timestamp":1764840418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge mapping of osteoporotic fractures: a bibliometric analysis from 2014 to 2024"],"prefix":"10.1007","volume":"21","author":[{"given":"Renwei","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-1357","authenticated-orcid":false,"given":"Xieyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"3","key":"1620_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0749-0690(02)00022-8","volume":"18","author":"M Srivastava","year":"2002","unstructured":"Srivastava M, Deal C (2002) Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med 18(3):529\u2013555","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"1620_CR2","first-page":"105","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. British Med Bullet 133(1):105\u201317","journal-title":"British Med Bullet"},{"key":"1620_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21106","author":"L Wang","year":"2021","unstructured":"Wang L et al (2021) Prevalence of osteoporosis and fracture in China. JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21106","journal-title":"JAMA Netw Open"},{"key":"1620_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-018-0549-y","author":"F Yu","year":"2019","unstructured":"Yu F, Xia W (2019) The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-018-0549-y","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1620_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cger.2014.01.001","volume":"30","author":"SM Friedman","year":"2014","unstructured":"Friedman SM, Mendelson DA (2014) Epidemiology of fragility fractures. Clin Geriatr Med 30(2):175\u2013181","journal-title":"Clin Geriatr Med"},{"key":"1620_CR6","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.171582","author":"A Agarwal","year":"2016","unstructured":"Agarwal A et al (2016) Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl. https:\/\/doi.org\/10.4103\/1008-682X.171582","journal-title":"Asian J Androl"},{"key":"1620_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1237864","author":"G Chu","year":"2023","unstructured":"Chu G, Niu H (2023) Knowledge mapping and global trends in the field of low-intensity pulsed ultrasound and endocrine and metabolic diseases: a bibliometric and visual analysis from 2012 to 2022. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1237864","journal-title":"Front Endocrinol"},{"key":"1620_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.918483","author":"K Cheng","year":"2022","unstructured":"Cheng K et al (2022) Mapping knowledge landscapes and emerging trends of the links between bone metabolism and diabetes mellitus: a bibliometric analysis from 2000 to 2021. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2022.918483","journal-title":"Front Public Health"},{"key":"1620_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1041360","author":"D Li","year":"2023","unstructured":"Li D et al (2023) Bibliometric study on clinical research of osteoporosis in adolescents. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2023.1041360","journal-title":"Front Public Health"},{"key":"1620_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.944444","author":"F Li","year":"2022","unstructured":"Li F et al (2022) Bibliometric and visualized analysis of exercise and osteoporosis from 2002 to 2021. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.944444","journal-title":"Front Med"},{"key":"1620_CR11","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8145","author":"S Zhou","year":"2019","unstructured":"Zhou S et al (2019) Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis. PeerJ. https:\/\/doi.org\/10.7717\/peerj.8145","journal-title":"PeerJ"},{"issue":"4","key":"1620_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/0118715303257269231011073100","volume":"24","author":"J Zhao","year":"2024","unstructured":"Zhao J et al (2024) Global publication trends and research hotspots of the immune system and osteoporosis: a bibliometric and visualization analysis from 2012 to 2022. Endocrine, Metabol Immune Disord - Drug Targets 24(4):455\u2013467","journal-title":"Endocrine, Metabol Immune Disord - Drug Targets"},{"key":"1620_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-024-01386-3","author":"S-Y Chen","year":"2024","unstructured":"Chen S-Y et al (2024) Bibliometric and visualized analysis of type 2 diabetic osteoporosis from 2013 to 2022. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-024-01386-3","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1620_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-8587(18)30308-5","volume":"7","author":"EJ Samelson","year":"2019","unstructured":"Samelson EJ et al (2019) Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diab Endocrinol 7(1):34\u201343","journal-title":"Lancet Diab Endocrinol"},{"issue":"2","key":"1620_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jocd.2016.03.003","volume":"19","author":"EM Lewiecki","year":"2016","unstructured":"Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry guidance. J Clin Densitom 19(2):127\u2013140","journal-title":"J Clin Densitom"},{"key":"1620_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-016-0278-z","author":"JA Kanis","year":"2016","unstructured":"Kanis JA et al (2016) A systematic review of intervention thresholds based on FRAX a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-016-0278-z","journal-title":"Arch Osteoporos"},{"key":"1620_CR17","unstructured":"<NEJM200105103441904.pdf>."},{"issue":"1","key":"1620_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3\u201344","journal-title":"Osteoporos Int"},{"issue":"10","key":"1620_CR19","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381","journal-title":"Osteoporos Int"},{"issue":"10","key":"1620_CR20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1359\/jbmr.080506","volume":"23","author":"BM Obermayer-Pietsch","year":"2008","unstructured":"Obermayer-Pietsch BM et al (2008) Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res 23(10):1591\u20131600","journal-title":"J Bone Miner Res"},{"issue":"10117","key":"1620_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL et al (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230\u2013240","journal-title":"Lancet"},{"key":"1620_CR22","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/S0020-1383(13)70013-5","volume":"44","author":"L Pietrogrande","year":"2013","unstructured":"Pietrogrande L, Raimondo E (2013) Teriparatide in the treatment of non-unions: scientific and clinical evidences. Injury 44:S54\u2013S57","journal-title":"Injury"},{"key":"1620_CR23","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1007\/s40520-013-0133-7","volume":"25","author":"A Nardi","year":"2013","unstructured":"Nardi A et al (2013) The bone anabolic therapy. Aging Clin Exp Res 25:S121\u2013S124","journal-title":"Aging Clin Exp Res"},{"issue":"9886","key":"1620_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","volume":"382","author":"JN Tsai","year":"2013","unstructured":"Tsai JN et al (2013) Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 382(9886):50\u201356","journal-title":"Lancet"},{"issue":"12","key":"1620_CR25","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/jbmr.4439","volume":"36","author":"JN Liu","year":"2021","unstructured":"Liu JN et al (2021) Patterns of teriparatide and sequential antiresorptive agent treatment among elderly female medicare beneficiaries. J Bone Miner Res 36(12):2309\u20132316","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1620_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40265-019-01072-6","volume":"79","author":"A Markham","year":"2019","unstructured":"Markham A (2019) Romosozumab: first global approval. Drugs 79(4):471\u2013476","journal-title":"Drugs"},{"issue":"3","key":"1620_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jbmr.3622","volume":"34","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM et al (2019) One year of romosozumab followed by two years of denosumab maintains fracture risk reductions: results of the FRAME extension study. J Bone Miner Res 34(3):419\u2013428","journal-title":"J Bone Miner Res"},{"issue":"7","key":"1620_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jbmr.3427","volume":"33","author":"F Cosman","year":"2018","unstructured":"Cosman F et al (2018) FRAME study: the foundation effect of building bone with 1 year of romosozumab leads to continued lower fracture risk after transition to denosumab. J Bone Miner Res 33(7):1219\u20131226","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1620_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcph.239","volume":"54","author":"D Padhi","year":"2014","unstructured":"Padhi D et al (2014) Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study. J Clin Pharmacol 54(2):168\u2013178","journal-title":"J Clin Pharmacol"},{"issue":"16","key":"1620_CR30","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"issue":"9","key":"1620_CR31","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1210\/jc.2017-02163","volume":"103","author":"EM Lewiecki","year":"2018","unstructured":"Lewiecki EM et al (2018) A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis. J Clin Endocrinol Metab 103(9):3183\u20133193","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1620_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jbmr.3051","volume":"32","author":"F Cosman","year":"2017","unstructured":"Cosman F, Nieves JW, Dempster DW (2017) Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res 32(2):198\u2013202","journal-title":"J Bone Miner Res"},{"key":"1620_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0332-0","author":"SM Dyer","year":"2016","unstructured":"Dyer SM et al (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. https:\/\/doi.org\/10.1186\/s12877-016-0332-0","journal-title":"BMC Geriatr"},{"key":"1620_CR34","first-page":"937","volume":"10","author":"AS Nazrun","year":"2014","unstructured":"Nazrun AS et al (2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag 10:937\u2013948","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"1620_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jbmr.4821","volume":"38","author":"CW Sing","year":"2023","unstructured":"Sing CW et al (2023) Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. J Bone Miner Res 38(8):1064\u20131075","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1620_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","volume":"29","author":"EM Lewiecki","year":"2018","unstructured":"Lewiecki EM et al (2018) Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int 29(3):717\u2013722","journal-title":"Osteoporos Int"},{"issue":"5","key":"1620_CR37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00198-015-3464-8","volume":"27","author":"H Orimo","year":"2016","unstructured":"Orimo H et al (2016) Hip fracture incidence in Japan: estimates of new patients in 2012 and 25-year trends. Osteoporos Int 27(5):1777\u20131784","journal-title":"Osteoporos Int"},{"issue":"9","key":"1620_CR38","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH et al (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29(9):1929\u20131937","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1620_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","volume":"4","author":"C-L Cheung","year":"2018","unstructured":"Cheung C-L et al (2018) An updated hip fracture projection in Asia: the Asian federation of osteoporosis societies study. Osteoporosis and sarcopenia 4(1):16\u201321","journal-title":"Osteoporosis and sarcopenia"},{"issue":"7","key":"1620_CR40","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00198-017-4009-0","volume":"28","author":"JA Kanis","year":"2017","unstructured":"Kanis JA et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28(7):2023\u20132034","journal-title":"Osteoporos Int"},{"issue":"7","key":"1620_CR41","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/jbmr.2462","volume":"30","author":"CI Li","year":"2015","unstructured":"Li CI et al (2015) Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan Diabetes Cohort study. J Bone Miner Res 30(7):1338\u20131346","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1620_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11914-015-0260-5","volume":"13","author":"L Oei","year":"2015","unstructured":"Oei L et al (2015) Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep 13(2):106\u2013115","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"1620_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jocd.2017.06.011","volume":"20","author":"C Poiana","year":"2017","unstructured":"Poiana C, Capatina C (2017) Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom 20(3):432\u2013443","journal-title":"J Clin Densitom"},{"issue":"3","key":"1620_CR44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00198-016-3804-3","volume":"28","author":"E Alacreu","year":"2017","unstructured":"Alacreu E, Moratal D, Arana E (2017) Opportunistic screening for osteoporosis by routine CT in Southern Europe. Osteoporos Int 28(3):983\u2013990","journal-title":"Osteoporos Int"},{"issue":"2","key":"1620_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ageing\/afv204","volume":"45","author":"S Hawley","year":"2016","unstructured":"Hawley S et al (2016) Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing 45(2):236\u2013242","journal-title":"Age Ageing"},{"issue":"11","key":"1620_CR46","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-015-3192-0","volume":"26","author":"MK Javaid","year":"2015","unstructured":"Javaid MK et al (2015) Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the FractureA\u00ae best practice framework tool. Osteoporos Int 26(11):2573\u20132578","journal-title":"Osteoporos Int"},{"issue":"7","key":"1620_CR47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.2180","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH et al (2014) The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system. J Bone Miner Res 29(7):1667\u20131674","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1620_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jbmr.4292","volume":"36","author":"J Smets","year":"2021","unstructured":"Smets J et al (2021) Machine learning solutions for osteoporosis-a review. J Bone Miner Res 36(5):833\u2013851","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1620_CR49","first-page":"1","volume":"17","author":"W Yu","year":"2024","unstructured":"Yu W (2024) Developing artificial intelligence for management of osteoporosis and fractures. Zhongguo Gu Zhi Shu Song Yu Gu Kuang Wu Yan Jiu Za Zhi 17(1):1\u201316","journal-title":"Zhongguo Gu Zhi Shu Song Yu Gu Kuang Wu Yan Jiu Za Zhi"},{"issue":"6","key":"1620_CR50","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3349\/ymj.2013.54.6.1321","volume":"54","author":"TK Yoo","year":"2013","unstructured":"Yoo TK et al (2013) Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning. Yonsei Med J 54(6):1321\u20131330","journal-title":"Yonsei Med J"},{"issue":"4","key":"1620_CR51","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00256-019-03342-6","volume":"49","author":"S Lee","year":"2020","unstructured":"Lee S et al (2020) The exploration of feature extraction and machine learning for predicting bone density from simple spine X-ray images in a Korean population. Skeletal Radiol 49(4):613\u2013618","journal-title":"Skeletal Radiol"},{"key":"1620_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00802-8","author":"JG Shim","year":"2020","unstructured":"Shim JG et al (2020) Application of machine learning approaches for osteoporosis risk prediction in postmenopausal women. Arch Osteoporos. https:\/\/doi.org\/10.1007\/s11657-020-00802-8","journal-title":"Arch Osteoporos"},{"key":"1620_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232969","author":"A Engels","year":"2020","unstructured":"Engels A et al (2020) Osteoporotic hip fracture prediction from risk factors available in administrative claims data-a machine learning approach. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0232969","journal-title":"PLoS ONE"},{"issue":"4","key":"1620_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00223-017-0238-7","volume":"100","author":"C Kruse","year":"2017","unstructured":"Kruse C, Eiken P, Vestergaard P (2017) Machine learning principles can improve hip fracture prediction. Calcif Tissue Int 100(4):348\u2013360","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1620_CR55","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jbmr.4494","volume":"37","author":"DE Whittier","year":"2022","unstructured":"Whittier DE et al (2022) Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk. J Bone Miner Res 37(3):428\u2013439","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1620_CR56","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s11914-021-00701-y","volume":"19","author":"V Pedoia","year":"2021","unstructured":"Pedoia V et al (2021) Augmenting osteoporosis imaging with machine learning. Curr Osteoporos Rep 19(6):699\u2013709","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"1620_CR57","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/BOR.0000000000000607","volume":"31","author":"U Ferizi","year":"2019","unstructured":"Ferizi U, Honig S, Chang G (2019) Artificial intelligence, osteoporosis and fragility fractures. Curr Opin Rheumatol 31(4):368\u2013375","journal-title":"Curr Opin Rheumatol"},{"key":"1620_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105484","author":"E Villamor","year":"2020","unstructured":"Villamor E et al (2020) Prediction of osteoporotic hip fracture in postmenopausal women through patient-specific FE analyses and machine learning. Comput Methods Programs Biomed. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105484","journal-title":"Comput Methods Programs Biomed"},{"key":"1620_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18147635","author":"WYO Yang","year":"2021","unstructured":"Yang WYO et al (2021) Development of machine learning models for prediction of osteoporosis from clinical health examination data. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18147635","journal-title":"Int J Environ Res Public Health"},{"key":"1620_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34817-6","author":"CM Deniz","year":"2018","unstructured":"Deniz CM et al (2018) Segmentation of the proximal femur from MR images using deep convolutional neural networks. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-34817-6","journal-title":"Sci Rep"},{"issue":"4","key":"1620_CR61","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jmri.26280","volume":"49","author":"U Ferizi","year":"2019","unstructured":"Ferizi U et al (2019) Artificial intelligence applied to osteoporosis: a performance comparison of machine learning algorithms in predicting fragility fractures from MRI data. J Magn Reson Imaging 49(4):1029\u20131038","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1620_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12938-018-0436-1","volume":"17","author":"AS Cruz","year":"2018","unstructured":"Cruz AS et al (2018) Artificial intelligence on the identification of risk groups for osteoporosis, a general review. BioMed Eng OnLine 17(1):12","journal-title":"BioMed Eng OnLine"},{"key":"1620_CR63","doi-asserted-by":"publisher","DOI":"10.1177\/20552076241257456","author":"MH Liu","year":"2024","unstructured":"Liu MH et al (2024) Predicting fracture risk for elderly osteoporosis patients by hybrid machine learning model. Digit Health. https:\/\/doi.org\/10.1177\/20552076241257456","journal-title":"Digit Health"},{"key":"1620_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10337","author":"SH Kong","year":"2020","unstructured":"Kong SH et al (2020) A novel fracture prediction model using machine learning in a community-based cohort. JBMR Plus. https:\/\/doi.org\/10.1002\/jbm4.10337","journal-title":"JBMR Plus"},{"key":"1620_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bone.2018.10.011","volume":"126","author":"SC Larsson","year":"2019","unstructured":"Larsson SC, Micha\u00eblsson K, Burgess S (2019) Mendelian randomization in the bone field. Bone 126:51\u201358","journal-title":"Bone"},{"key":"1620_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bone.2018.09.015","volume":"117","author":"Q Zhang","year":"2018","unstructured":"Zhang Q et al (2018) Age at menarche and osteoporosis: a Mendelian randomization study. Bone 117:91\u201397","journal-title":"Bone"},{"issue":"7","key":"1620_CR67","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/jbmr.4296","volume":"36","author":"BS Ma","year":"2021","unstructured":"Ma BS et al (2021) Causal associations of anthropometric measurements with fracture risk and bone mineral density: a Mendelian randomization study. J Bone Miner Res 36(7):1281\u20131287","journal-title":"J Bone Miner Res"},{"key":"1620_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/srep33202","author":"SS Li","year":"2016","unstructured":"Li SS et al (2016) Genetically low vitamin D levels, bone mineral density, and bone metabolism markers: a Mendelian randomisation study. Sci Rep. https:\/\/doi.org\/10.1038\/srep33202","journal-title":"Sci Rep"},{"key":"1620_CR69","doi-asserted-by":"crossref","unstructured":"Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, Ohlsson C, Richards JB, Rivadeneira F (2018) Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. bmj. 362.","DOI":"10.1136\/bmj.k3225"},{"key":"1620_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1163258","author":"J Mei","year":"2023","unstructured":"Mei J et al (2023) Investigating the causal relationship between ankylosing spondylitis and osteoporosis in the European population: a bidirectional Mendelian randomization study. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1163258","journal-title":"Front Immunol"},{"issue":"11","key":"1620_CR71","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/eci.12677","volume":"46","author":"N Veronese","year":"2016","unstructured":"Veronese N et al (2016) Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest 46(11):920\u2013930","journal-title":"Eur J Clin Invest"},{"key":"1620_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.716681","author":"B He","year":"2021","unstructured":"He B et al (2021) Causal effect of blood pressure on bone mineral density and fracture: a Mendelian randomization study. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2021.716681","journal-title":"Front Endocrinol"},{"issue":"10","key":"1620_CR73","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.18632\/aging.203029","volume":"13","author":"YQ Liu","year":"2021","unstructured":"Liu YQ et al (2021) Rheumatoid arthritis and osteoporosis: a bi-directional Mendelian randomization study. Aging 13(10):14109\u201314130","journal-title":"Aging"},{"issue":"21","key":"1620_CR74","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/hmg\/ddab158","volume":"30","author":"XH Yu","year":"2021","unstructured":"Yu XH et al (2021) Rheumatoid arthritis and osteoporosis: shared genetic effect, pleiotropy and causality. Hum Mol Genet 30(21):1932\u20131940","journal-title":"Hum Mol Genet"},{"key":"1620_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1196269","author":"SF Wu","year":"2023","unstructured":"Wu SF et al (2023) The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1196269","journal-title":"Front Endocrinol"},{"key":"1620_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148107","author":"DY Xu","year":"2023","unstructured":"Xu DY et al (2023) The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1148107","journal-title":"Front Immunol"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01620-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T11:01:57Z","timestamp":1764846117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01620-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01620-6","relation":{},"ISSN":["1862-3514"],"issn-type":[{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}